The myriad factors that increase the risk of VTE in malignancy have been hypothesized to include TF produced by the tumor, which can activate the coagulation cascade, compression of vessels by the tumors with associated venous stasis, and prolonged immobilization of the patient, amongst others [6,7]. This evidence concerns the gene TF and neoplasm.